TuHURA details 5M-share 2026 inducement plan
TuHURA Biosciences adopted a 2026 inducement equity plan reserving 5 million shares for future awards to new employees, with no grants made yet.
Rhea-AI Filing Summary
TuHURA Biosciences, Inc. (HURA) filed an amendment to clarify details of its newly adopted 2026 Inducement Equity Incentive Plan, which the Board approved on September 10, 2026 under Nasdaq Listing Rule 5635(c)(4). The plan reserves 5,000,000 shares of common stock for equity awards to new employees as a material inducement to employment. Awards may include nonqualified stock options and other stock-based awards, but no incentive stock options. As of adoption, no equity awards have been granted, and the Board currently expects all awards to be stock options with an exercise price at or above the closing price on the grant date. Shares reserved under the plan will only become issued and outstanding if the options granted to new employees vest and are exercised.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Shares reserved under 2026 Inducement Plan: 5,000,000 shares
Plan adoption date: September 10, 2026
Par value of common stock: $0.001 per share
+2 more
5 metrics
Shares reserved under 2026 Inducement Plan
5,000,000 shares
Reserved by the Board of Directors for issuance under the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan
Plan adoption date
September 10, 2026
Date the Board of Directors adopted the 2026 Inducement Equity Incentive Plan
Par value of common stock
$0.001 per share
Par value of TuHURA Biosciences, Inc. common stock reserved under the Inducement Plan
Nasdaq rule referenced
Nasdaq Listing Rule 5635(c)(4)
Rule allowing adoption of the Inducement Plan without stockholder approval for inducement grants
Filing signature date
September 17, 2026
Date the report was signed by Chief Financial Officer Dan Dearborn
Key Terms
Inducement Equity Incentive Plan, Nasdaq Listing Rule 5635(c)(4), nonqualified stock options, stock appreciation rights, +2 more
6 terms
Inducement Equity Incentive Plan financial
"adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan"
An inducement equity incentive plan is a program that grants employees or executives company shares or stock options to motivate and reward their work, often as a way to attract new talent. It aligns their interests with the company's success, encouraging them to contribute to long-term growth. For investors, such plans can influence a company's stock performance and overall financial health by motivating key personnel.
Nasdaq Listing Rule 5635(c)(4) regulatory
"The Inducement Plan was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
nonqualified stock options financial
"Awards under the Inducement Plan may consist of nonqualified stock options, stock appreciation rights"
A nonqualified stock option is a company-issued right that lets an employee or contractor buy shares later at a preset price, like a coupon to purchase stock regardless of the market price. It matters to investors because when the option is used the recipient owes ordinary-income tax on the difference between market and preset price, which affects the holder’s financial decisions and can change the company’s share count and reported expenses.
stock appreciation rights financial
"Awards under the Inducement Plan may consist of nonqualified stock options, stock appreciation rights, stock"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
restricted stock units financial
"stock, restricted stock, restricted stock units, performance shares, performance units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TuHURA Biosciences (HURA) change or clarify in this 8-K/A filing?
The company added details about its 2026 Inducement Equity Incentive Plan, clarifying that no awards have been granted yet, that grants will be announced via press release, are expected to be stock options priced at or above the closing stock price, and only become outstanding when vested and exercised.
Who is eligible to receive awards under TuHURA Biosciences’ 2026 Inducement Plan (HURA)?
Only individuals who meet the standard for inducement grants under Nasdaq Listing Rule 5635(c)(4) are eligible. This means awards are limited to new employees receiving equity as a material inducement to entering into employment with TuHURA Biosciences or its subsidiaries.
What types of awards can be granted under HURA’s 2026 Inducement Equity Incentive Plan?
Awards may include nonqualified stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance shares, performance units, and other stock-based awards. The plan explicitly states that no incentive stock options may be granted under it.
Has TuHURA Biosciences (HURA) granted any equity awards under the 2026 Inducement Plan yet?
No. The company states that, as of the date of adoption of the Inducement Plan, it has not granted any equity awards under the plan. It also states that all future grants will be announced in a press release in accordance with Nasdaq Listing Rule 5635(c)(4).
How will option pricing work under TuHURA Biosciences’ 2026 Inducement Plan (HURA)?
The Board currently expects that all equity awards under the Inducement Plan will be granted as stock options to new employees with an exercise price equal to or greater than the closing price of TuHURA Biosciences’ common stock on the date of grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
